Scinovex
review Open AccessTop 1% cited

The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection

Clinical Infectious Diseases · 2011 · Vol. 52(6) · pp. 793–800
Edward M. GardnerMargaret McleesJohn F. SteinerCarlos del Rı́oW. J. Burman

Abstract

For individuals with human immunodeficiency virus (HIV) infection to fully benefit from potent combination antiretroviral therapy, they need to know that they are HIV infected, be engaged in regular HIV care, and receive and adhere to effective antiretroviral therapy. Test-and-treat strategies for HIV prevention posit that expanded testing and earlier treatment of HIV infection could markedly decrease ongoing HIV transmission, stemming the HIV epidemic. However, poor engagement in care for HIV-infected individuals will substantially limit the effectiveness of test-and-treat strategies. We review the spectrum of engagement in care for HIV-infected individuals in the United States and apply this information to help understand the magnitude of the challenges that poor engagement in care will pose to test-and-treat strategies for HIV prevention.

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskHIV Research and TreatmentMedicineHuman immunodeficiency virus (HIV)Treatment as preventionTransmission (telecommunications)Antiretroviral therapyTest (biology)Hiv testIntensive care medicineImmunologyFamily medicine

MeSH terms

HumansPatient Acceptance of Health CareUnited StatesHIV InfectionsAnti-HIV AgentsAntiretroviral Therapy, Highly Active

Funding

  • National Institute of Mental Health
  • National Institute of Allergy and Infectious Diseases
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.